Provided by Tiger Trade Technology Pte. Ltd.

Tyra Biosciences, Inc.

26.09
+0.04000.15%
Post-market: 26.090.00000.00%16:10 EDT
Volume:320.07K
Turnover:8.34M
Market Cap:1.55B
PE:-10.86
High:26.42
Open:25.99
Low:25.18
Close:26.05
52wk High:40.65
52wk Low:11.70
Shares:59.49M
Float Shares:35.21M
Volume Ratio:0.78
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4031
EPS(LYR):-2.0125
ROE:-45.31%
ROA:-28.46%
PB:4.39
PE(LYR):-12.96

Loading ...

Company Profile

Company Name:
Tyra Biosciences, Inc.
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
87
Office Location:
2656 State Street,Carlsbad,California,United States
Zip Code:
92008
Fax:
- -
Introduction:
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in Phase 1/2 clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in Phase 1 clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.

Directors

Name
Position
Robert More
Chairman of the Board, Independent Director
Todd Harris
Chief Executive Officer,Director and President
Adele M. Gulfo
Independent Director
Habib J. Dable
Independent Director
Jake Simson
Independent Director
Melissa McCracken
Independent Director
Rehan Verjee
Independent Director
S. Michael Rothenberg
Independent Director
Susan Moran
Independent Director

Shareholders

Name
Position
Todd Harris
Chief Executive Officer,Director and President
Bhavesh Ashar
Chief Operating Officer
Alan Fuhrman
Chief Financial Officer
Douglas Warner
Chief Medical Officer